- Home
- MKZR vs TNON Comparison
MKZR vs TNON Comparison
Compare MKZR & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKZR
- TNON
- Stock Information
- Founded
- MKZR 2012
- TNON 2012
- Country
- MKZR United States
- TNON United States
- Employees
- MKZR N/A
- TNON N/A
- Industry
- MKZR
- TNON Medical Specialities
- Sector
- MKZR
- TNON Health Care
- Exchange
- MKZR Nasdaq
- TNON Nasdaq
- Market Cap
- MKZR 10.3M
- TNON 8.9M
- IPO Year
- MKZR N/A
- TNON 2022
- Fundamental
- Price
- MKZR $4.20
- TNON $1.14
- Analyst Decision
- MKZR
- TNON Strong Buy
- Analyst Count
- MKZR 0
- TNON 2
- Target Price
- MKZR N/A
- TNON $5.50
- AVG Volume (30 Days)
- MKZR 32.1K
- TNON 138.5K
- Earning Date
- MKZR 11-14-2025
- TNON 11-13-2025
- Dividend Yield
- MKZR 24.69%
- TNON N/A
- EPS Growth
- MKZR N/A
- TNON N/A
- EPS
- MKZR N/A
- TNON N/A
- Revenue
- MKZR $20,994,778.00
- TNON $3,233,000.00
- Revenue This Year
- MKZR N/A
- TNON $17.85
- Revenue Next Year
- MKZR N/A
- TNON $85.60
- P/E Ratio
- MKZR N/A
- TNON N/A
- Revenue Growth
- MKZR 3.63
- TNON N/A
- 52 Week Low
- MKZR $3.86
- TNON $0.85
- 52 Week High
- MKZR $50.00
- TNON $5.85
- Technical
- Relative Strength Index (RSI)
- MKZR 38.42
- TNON 46.53
- Support Level
- MKZR $3.92
- TNON $1.10
- Resistance Level
- MKZR $4.86
- TNON $1.16
- Average True Range (ATR)
- MKZR 0.41
- TNON 0.06
- MACD
- MKZR -0.05
- TNON -0.00
- Stochastic Oscillator
- MKZR 20.88
- TNON 41.38
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.